Some extremely low-birth weight infants develop hyperglycaemia, which may persist for more than 2 weeks extending to the post-acute phase among those born extremely premature at <24 weeks of gestation, a study has found.
The separation of newborns from their mothers due to control measures for the novel coronavirus disease (COVID-19) pandemic lowers the rate of breastfeeding, both in the hospital and at home, a recent study has found.
Investigational drug AMO-02 (tideglusib) has a favourable risk-benefit and pharmacokinetic profile for congenital and childhood-onset type 1 myotonic dystrophy, a recent phase II study has shown. Further studies on tideglusib are warranted.
Antiviral treatment with tenofovir alafenamide fumarate (TAF) during pregnancy in highly viraemic mothers effectively prevents mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with no safety concerns, according to two studies presented during the AASLD 2020 Liver Meeting.